Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Two Functional Variants of AP-1 Complexes Composed of either gamma 2 or gamma 1 Subunits Are Independently Required for Major Histocompatibility Complex Class I Downregulation by HIV-1 Nef

Texto completo
Autor(es):
Tavares, Lucas A. [1, 2] ; de Carvalho, V, Julianne ; Costa, Cristina S. [3, 4] ; Silveira, Roberta M. [3, 4] ; de Carvalho, Andreia N. [3, 4] ; Donadi, Eduardo A. [5] ; daSilva, Luis L. P. [3, 4]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Ribeirao Preto, SP - Brazil
[2] Univ Sao Paulo, Ctr Virol Res, Ribeirao Preto Med Sch, Ribeirao Preto, SP - Brazil
[3] de Carvalho, Julianne, V, Univ Sao Paulo, Ctr Virol Res, Ribeirao Preto Med Sch, Ribeirao Preto, SP - Brazil
[4] de Carvalho, Julianne, V, Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Ribeirao Preto, SP - Brazil
[5] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, SP - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: Journal of Virology; v. 94, n. 7 APR 2020.
Citações Web of Science: 0
Resumo

The HIV-1 accessory protein Nef downregulates the cell surface expression of major histocompatibility complex class I (MHC-I) molecules to facilitate virus spreading. The Nef-induced downregulation of MHC-I molecules such as HLA-A requires the clathrin adaptor protein 1 (AP-1) complex. The cooperative interaction of Nef, AP-1, and the cytosolic tail (CT) of HLA-A leads to a redirection of HLA-A targeting from the trans-Golgi network (TGN) to lysosomes for degradation. Although the gamma-adaptin subunit of AP-1 has two distinct isoforms (gamma 1 and gamma 2), which may form two AP-1 complex variants, so far, only the importance of AP-1 gamma 1 in MHC-I downregulation by Nef has been investigated. Here, we report that the AP-1 gamma 2 isoform also participates in this process. We found that AP-1 gamma 2 forms a complex with Nef and HLA-A2\_CT and that this interaction depends on the Y-320 residue in HLA-A2\_CT and Nef expression. Moreover, Nef targets AP-1 gamma 1 and AP-1 gamma 2 to different compartments in T cells, and the depletion of either AP-1 variant impairs the Nef-mediated reduction of total endogenous HLA-A levels and rescues HLA-A levels on the cell surface. Finally, immunofluorescence and immunoelectron microscopy analyses reveal that the depletion of gamma 2 in T cells compromises both the Nef-mediated retention of HLA-A molecules in the TGN and targeting to multivesicular bodies/late endosomes. Altogether, these results show that in addition to AP-1 gamma 1, Nef also requires the AP-1 gamma 2 variant for efficient MHC-I downregulation. IMPORTANCE HIV-1 Nef mediates evasion of the host immune system by inhibiting MHC-I surface presentation of viral antigens. To achieve this goal, Nef modifies the intracellular trafficking of MHC-I molecules in several ways. Despite being the subject of intense study, the molecular details underlying these modifications are not yet fully understood. Adaptor protein 1 (AP-1) plays an essential role in the Nef-mediated downregulation of MHC-I molecules such as HLA-A in different cell types. However, AP-1 has two functionally distinct variants composed of either gamma 1 or gamma 2 subunit isoforms. Because previous studies on the role of AP-1 in MHC-I downregulation by Nef focused on AP-1 gamma 1, an important open question is the participation of AP-1 gamma 2 in this process. Here, we show that AP-1 gamma 2 is also essential for Nef-mediated depletion of surface HLA-A molecules in T cells. Our results indicate that Nef hijacks AP-1 gamma 2 to modify HLA-A intracellular transport, redirecting these proteins to lysosomes for degradation. (AU)

Processo FAPESP: 16/05945-1 - Mecanismos envolvidos na montagem e externalização de Zika vírus em células humanas
Beneficiário:Roberta Maraninchi Silveira
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 16/18207-9 - Caracterização de vias de tráfego de proteínas envolvidas na biogênese e funcionamento de lisossomos em células humanas
Beneficiário:Lucas Alves Tavares
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 15/26667-7 - Identificação de organelas e fatores celulares envolvidos na montagem e brotamento do hantavírus Araraquara (ARAQV)
Beneficiário:Julianne Vargas de Carvalho
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 14/02438-6 - Estudos com Bunyaviridae causadores de doença
Beneficiário:Luiz Tadeu Moraes Figueiredo
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 18/08966-5 - Estudo dos mecanismos celulares pelos quais o HIV-1 antagoniza a ação antiviral das proteínas transmembrana induzidas por interferon (IFITMs)
Beneficiário:Cristina Santos da Costa
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 18/00297-7 - Estudo dos efeitos da proteína Nef do HIV-1 no sistema de endomembranas da célula hospedeira e suas implicações na patogênese viral
Beneficiário:Luis Lamberti Pinto da Silva
Modalidade de apoio: Auxílio à Pesquisa - Regular